Reviewing Solesence (SLSN) and Its Peers

Solesence (NASDAQ:SLSN) is one of 55 publicly-traded companies in the “Personal Care Products” industry, but how does it contrast to its competitors? We will compare Solesence to related businesses based on the strength of its dividends, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

Valuation and Earnings

This table compares Solesence and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Solesence	$62.06 million	$1.79 million	-28.57
Solesence Competitors	$8.28 billion	$1.11 billion	8.54

Solesence’s competitors have higher revenue and earnings than Solesence. Solesence is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a summary of recent ratings and target prices for Solesence and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solesence	1	0	0	0	1.00
Solesence Competitors	897	2928	3657	228	2.42

As a group, “Personal Care Products” companies have a potential upside of 1.52%. Given Solesence’s competitors stronger consensus rating and higher probable upside, analysts clearly believe Solesence has less favorable growth aspects than its competitors.

Institutional & Insider Ownership

70.2% of Solesence shares are owned by institutional investors. Comparatively, 48.6% of shares of all “Personal Care Products” companies are owned by institutional investors. 4.8% of Solesence shares are owned by insiders. Comparatively, 11.7% of shares of all “Personal Care Products” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Solesence and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Solesence	-3.40%	-11.58%	-3.79%
Solesence Competitors	-5.56%	-65.90%	-0.31%

Risk & Volatility

Solesence has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500. Comparatively, Solesence’s competitors have a beta of 0.80, indicating that their average stock price is 20% less volatile than the S&P 500.

Summary

Solesence competitors beat Solesence on 9 of the 13 factors compared.

About Solesence

Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications. The company was incorporated in 1989 and is headquartered in Romeoville, Illinois.